Clean Science and Technology Limited IPO
Clean Science and Technology Limited is among the few companies focused globally entirely on producing innovative technologies using the in-house catalytic processes that are environment-friendly and cost-competitive as well. As per F&S reports, this has enabled the company to emerge as the largest global manufacturer of specialty chemicals in terms of manufacturing capacity as of 31 December 2020.
The company manufactures critical specialty chemicals like Pharmaceutical Intermediates including Guaiacol and DCC, Performance Chemicals including MEHQ, BHA, and AP, and FMCG Chemicals including 4-MAP and Anisole. Within 17 years of its inception, the company is now the largest manufacturer of MEHQ, BHA, Anisole, and 4-MAP globally in terms of manufacturing capacity.
Their specialty chemicals have diverse applications which cater to customers across industries. Their customers include distributors & manufacturers in India as well as other international markets like Europe, China, the USA, Taiwan, Japan & Korea. The revenue from operations of the company from sales outside India was around 68.76% & 65.36% of their total revenue from operations in the Fiscal Year 2020 and 9-months ended 31 December 2020.
The promoter of the company is Ashok Ramnarayan Boob, Krishna Kumar Ramnarayan Boob, Siddhartha Ashok Sikchi, and Parth Ashok Maheshwari.
Strengths of the Company
- Through its consistent R&D initiatives, the company has a good track record of strategic process innovation
- Experienced senior management team & promoters with extensive knowledge
- Strong relationships with key customers
- The company is among the largest producers of critical specialty chemicals globally which is being used in various industries & across geographies
- Strong record of financial performance
- Automated facilities & processes with proven commercialization & design capabilities
Purpose of the IPO
As it is an offer for sale by promoters, the company will not be having any proceeds from IPO.
Financial Performance of the company
| For the 9-month period ended 31st December 2020 | FY 2020 | FY 2019 | FY 2018 | |
| Total Revenue | 398.46 | 430.16 | 404.56 | 247.23 |
| Total Expenses | 202.64 | 247.84 | 268.02 | 176.97 |
| Profit After Tax | 145.26 | 139.63 | 97.65 | 48.89 |
| Total Assets | 571.18 | 429.87 | 327.47 | 236.10 |
*All the values are in crores and as per DRHP.
Valuation of the Company:
| For the 9-month period ended 31st December 2020 | FY 2020 | FY 2019 | FY 2018 | |
| Basic Earnings per Share (EPS) | 13.68 | 13.15 | 9.19 | 4.60 |
| Diluted Earnings per Share (EPS) | 13.68 | 13.15 | 9.19 | 4.60 |
| Return on Net Worth (%) | 29.65% | 40.82% | 35.90% | 26.03% |
| Net Assets Value per Equity share | 46.13 | 32.21 | 25.61 | 17.69 |
*As per DRHP.
Clean Science and Technology Limited IPO
IPO details:
| Face Value | ₹1 per equity share |
| Market Lot | 16 Shares |
| Minimum Order Quantity | 16 Shares |
| Price Band | ₹880- ₹900 per equity share |
| Issue type | Book Built Issue IPO |
| Issue Size | ₹1,546.62 Crores |
| Offer for Sale | ₹1,546.62 Crores |
| Listing | NSE, BSE |
Important IPO dates
| Open Date | 07th July 2021 |
| Close Date | 09th July 2021 |
| Basis of Allotment Date | 14th July 2021 |
| Initiation of Refunds | 15th July 2021 |
| The credit of shares to Demat Account | 16th July 2021 |
| Listing Date | 19th July 2021 |
Allocation Quota:
| Category | Portion |
| Qualified Institutional Buyers (QIBs) | Not more than 50% |
| Non- Institutional Buyers (NIIs) | Not less than 15% |
| Retail Investors | Not less than 35% |
Check your Clean Science and Technology Limited IPO allotment status here:
Link Intime IPO allotment Status: Click here
BSE IPO Allotment Status: Click here
NSE IPO Allotment Status: Click here